Sepsis Alliance Summit 2025

Pancreatic Stone Protein: Early and Rapid Sepsis Detection Across Patient Pathways

• 25 September 2025
• 17h25
• Online

This session is part of Sepsis Alliance Summit 2025.

In this sponsored session, the presenters will share a novel approach to enhance the early identification of patients who are at risk of developing sepsis by combining pancreatic stone protein (PSP), an early warning biomarker of sepsis, with commonly used Risk Assessment screening tools in ED triage. They will share recent clinical results and a planned study designed to strengthen the case for using PSP in the ED.

 

Speakers

• Andrew Shorr, MD, MBA, Section Director, Pulmonary and Critical Care Medicine, Medstar Washington Hospital Center (MWHC)
• Evangelos J. Giamarellos-Bourboulis, MD, PhD, Professor of Internal Medicine and Infectious Diseases, Medical School of the National and Kapodistrian University of Athens
• Patrick Pestalozzi, MBA, Chief Executive Officer, Abionic

 

FREE REGISTRATION: https://learn.sepsis.org/products/abionic-sponsored-session-pancreatic-stone-protein-early-and-rapid-sepsis-detection-across-patient-pathways